Beryl Drugs Limited

BSE:524606 株式レポート

時価総額:₹187.3m

Beryl Drugs 過去の業績

過去 基準チェック /26

Beryl Drugs has been growing earnings at an average annual rate of 20.2%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 21.4% per year. Beryl Drugs's return on equity is 6.8%, and it has net margins of 2.4%.

主要情報

20.2%

収益成長率

20.2%

EPS成長率

Pharmaceuticals 業界の成長17.5%
収益成長率21.4%
株主資本利益率6.8%
ネット・マージン2.4%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

収支内訳

Beryl Drugs の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

BSE:524606 収益、費用、利益 ( )INR Millions
日付収益収益G+A経費研究開発費
30 Jun 242496200
31 Mar 242678200
31 Dec 2329912190
30 Sep 2330410190
30 Jun 2330111180
31 Mar 232698170
31 Dec 222422150
30 Sep 221930150
30 Jun 22149-8130
31 Mar 22146-7130
31 Dec 21172-1140
30 Sep 21161-1130
30 Jun 211608120
31 Mar 211412120
31 Dec 20111-4110
30 Sep 20113-2110
30 Jun 20113-5100
31 Mar 201280100
31 Dec 19120790
30 Sep 19128890
30 Jun 19130790
31 Mar 19130690
31 Dec 18143890
30 Sep 18148790
30 Jun 181451180
31 Mar 181521080
31 Dec 17141770
30 Sep 17130580
30 Jun 17128190
31 Mar 17113-4100
31 Dec 161020110
30 Sep 161051120
30 Jun 161152130
31 Mar 161312120
31 Dec 151501140
30 Sep 151501220
30 Jun 151463400
31 Mar 151331120
31 Dec 141211240
30 Sep 141302220
30 Jun 141372220
31 Mar 141463210
31 Dec 131352170

質の高い収益: 524606 has high quality earnings.

利益率の向上: 524606's current net profit margins (2.4%) are lower than last year (3.6%).


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 524606's earnings have grown significantly by 20.2% per year over the past 5 years.

成長の加速: 524606's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

収益対業界: 524606 had negative earnings growth (-43.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (19.1%).


株主資本利益率

高いROE: 524606's Return on Equity (6.8%) is considered low.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘